P0613 PREMEDICATION AND INFUSION REACTIONS WITH INFLIXIMAB: RESULTS FROM A PEDIATRIC INFLAMMATORY BOWEL DISEASE CONSORTIUM
Jonathan E. Markowitz(University of South Carolina), Robert N. Baldassano(Children's Hospital of Philadelphia), George D. Ferry(Baylor College of Medicine), Barbara S. Kirschner(Comer Children's Hospital), Petar Mamula(Children's Hospital of Philadelphia), Melvin B. Heyman(University of California, San Francisco), T. Smith, Harland S. Winter(Philadelphia University), B. D. Gold(Emory University), S Cohen(Troy Gastroenterology), Melissa A. Shepanski(Children's Hospital of Philadelphia), P. L. Fain(Texas Children's Hospital)
Cited by 1
Related Papers
Human gut microbiome viewed across age and geography
|Nature|2012|7.9k
Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes
|Science|2011|6.6k
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
|Cell Host & Microbe|2014|3.3k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k